Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ping An Biomedical (PASW) Accumulated Expenses (2024 - 2025)

Ping An Biomedical filings provide 2 years of Accumulated Expenses readings, the most recent being $6532.0 for Q3 2025.

  • On a quarterly basis, Accumulated Expenses rose 164.64% to $6532.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $6532.0, a 164.64% increase, with the full-year FY2025 number at $6567.0, up 166.06% from a year prior.
  • Accumulated Expenses hit $6532.0 in Q3 2025 for Ping An Biomedical, up from $2468.3 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $6532.0 in Q3 2025 to a low of $2468.3 in Q3 2024.